A Multicenter Application of the 2018 Banff Classification for BK Polyomavirus-associated Nephropathy in Renal Transplantation
- PMID: 30896679
- DOI: 10.1097/TP.0000000000002712
A Multicenter Application of the 2018 Banff Classification for BK Polyomavirus-associated Nephropathy in Renal Transplantation
Abstract
Background: With current immunosuppressive regimens, BK polyomavirus-associated nephropathy (BKPyVAN) is still a matter of concern. Stratification of patients at risk for allograft loss is of uttermost importance to guide treatment choice and assess prognosis. In 2018, the Banff working group proposed a classification scheme for the prognosis of BKPyVAN, but external application on independent cohorts is yet to be performed. We investigated how the 2018 Banff classification would perform in a multicenter cohort comprising 50 cases of biopsy-proven BKPyVAN compared to previously published classification systems.
Methods: We analyzed consecutive BKPyVAN cases from two Dutch university hospitals between 2002 and 2013, retrieved clinical data, and scored all biopsies according to the Banff 2018 classification, and as a comparison, 4 previously proposed BKPyVAN classification systems. We used estimated glomerular filtration rate trajectories and death-censored graft survival as primary endpoints.
Results: The 2018 Banff classification did not associate with estimated glomerular filtration rate decline or graft failure and performed only slightly better than the 4 previously proposed classifiers. Anti-human leukocyte antigen donor-specific antibodies (DSAs), especially in combination with ongoing biopsy-proven BKPyVAN on follow-up, did correlate with graft function and survival. Patients who were DSA+/BKPyVAN+ on follow-up had more inflammation at the baseline biopsy, which by itself was not associated with graft outcomes.
Conclusions: Neither the 2018 Banff BKPyVAN classification nor previously published stratification systems could be applied to our multicenter patient cohort. Our data suggest that there might be a prognostic value for follow-up biopsies and DSA measurements to improve risk stratification after BKPyVAN, although prospective multicenter efforts with protocol measurements are needed to confirm this.
Similar articles
-
Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.Transpl Infect Dis. 2019 Apr;21(2):e13058. doi: 10.1111/tid.13058. Epub 2019 Mar 1. Transpl Infect Dis. 2019. PMID: 30730102
-
Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.Front Immunol. 2020 Aug 19;11:1763. doi: 10.3389/fimmu.2020.01763. eCollection 2020. Front Immunol. 2020. PMID: 32973745 Free PMC article.
-
Granulomatous inflammation in BK polyomavirus-associated nephropathy.Transpl Infect Dis. 2018 Oct;20(5):e12939. doi: 10.1111/tid.12939. Epub 2018 Jun 22. Transpl Infect Dis. 2018. PMID: 29863293
-
Characterization of BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant recipients using transcriptomic analysis: a comprehensive scoping review.Pathog Dis. 2025 Jan 30;83:ftaf006. doi: 10.1093/femspd/ftaf006. Pathog Dis. 2025. PMID: 40705457
-
Banff 2013 update: Pearls and pitfalls in transplant renal pathology.Nephrology (Carlton). 2015 Jul;20 Suppl 2:2-8. doi: 10.1111/nep.12474. Nephrology (Carlton). 2015. PMID: 26031578 Review.
Cited by
-
Routine immunohistochemistry study for polyomavirus BK nephropathy in transplanted kidney biopsies, is it recommended?BMC Nephrol. 2021 Jun 18;22(1):226. doi: 10.1186/s12882-021-02444-5. BMC Nephrol. 2021. PMID: 34139999 Free PMC article.
-
Clinicopathological Correlation of Polyomavirus Nephropathy in Renal Allograft Recipients According to the Banff 2018 Classification.Cureus. 2023 Dec 21;15(12):e50910. doi: 10.7759/cureus.50910. eCollection 2023 Dec. Cureus. 2023. PMID: 38249254 Free PMC article.
-
Polyomavirus nephropathy: diagnosis, histologic features, and differentiation from acute rejection.Clin Transplant Res. 2024 Jun 30;38(2):71-89. doi: 10.4285/ctr.24.0006. Epub 2024 Apr 23. Clin Transplant Res. 2024. PMID: 38725187 Free PMC article. Review.
-
Peritubular and Tubulointerstitial Inflammation as Predictors of Impaired Viral Clearance in Polyomavirus Nephropathy.J Clin Med. 2024 Sep 25;13(19):5714. doi: 10.3390/jcm13195714. J Clin Med. 2024. PMID: 39407774 Free PMC article.
-
BK Polyomavirus-associated nephropathy - diagnostic and treatment standard.Nephrol Dial Transplant. 2025 Apr 1;40(4):651-661. doi: 10.1093/ndt/gfaf002. Nephrol Dial Transplant. 2025. PMID: 39794277 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical